Supplementary Figure 1 from Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells

PDF file - 705K, Supplemental Figure 1: Representative gating strategy for the evaluation of patient-derived samples.</p

Supplementary Figure 3 from Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells

PDF file - 551K, Supplemental Figure 3: Representative CXCR3 and CLA staining in tetramer-negative cell populations.</p

Supplementary Figure 2 from Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells

PDF file - 548K, Supplemental Figure 2: Representative staining for surface and intracellular CXCR3.</p

Supplementary Table 1 from Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells

PDF file - 45K, Supplemental Table I: Effect of GM-CSF in vaccine on the expression of CXCR3 and CLA by tetramer-positive CD8+ T cells.</p

Figure S2 from IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

S2: IAP antagonist treatment skewsT-cell development toward the CD8 lineage in fetal thymic organ culture (FTOC).</p

Figure S1 from IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

S1: Structure of IAP antagonists</p

Figure S3 from IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

S3: IAP antagonism alone does not induce apoptosis of iNKT cells or conventional T cells.</p

Supplemental Figure Legends from IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

Figure legends</p

Figure S4 from IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

S4: CD1d knockout mice show a significant contribution of the costimulatory effects of LBW-242 on cytokine production by CD4+ T cells.</p

Supplemental Figures 1 - 10 from Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease

Supplemental Figure 1: Mice were given intravenous B16 injection on day 0. Supplemental Figure 2: Mice were given intravenous B16 injection on day 0.Supplemental Figure 3: Induced Braf/Pten tumors were harvested at 25 days or 40 days post-induction, corresponding to early (~5mm2) or late (~25mm2) tumors. Supplemental Figure 4: Chemokine production in melanoma. Supplemental Figure 5: Representative gating strategy for extracellular and intracellular staining. Supplemental Figure 6: Representative flow cytometry of Pmel CD8+ T cells stained for CD8 and CXCR3 after in vitro activation but before adoptive transfer. Supplemental Figure 7: Mice were given intravenous B16 injection on day 0. Supplemental Figure 8: Splenocytes were harvested from Pmel and Pmel-CXCR3-/- mice. Supplemental Figure 9: Naïve mice were injected (I.P.) with 50mg/kg aminophylline three times over the course of nine days. Supplemental Figure 10: Regulatory T cells in advanced melanomas express CD73.</p